JP2019520852A5 - - Google Patents

Download PDF

Info

Publication number
JP2019520852A5
JP2019520852A5 JP2019514870A JP2019514870A JP2019520852A5 JP 2019520852 A5 JP2019520852 A5 JP 2019520852A5 JP 2019514870 A JP2019514870 A JP 2019514870A JP 2019514870 A JP2019514870 A JP 2019514870A JP 2019520852 A5 JP2019520852 A5 JP 2019520852A5
Authority
JP
Japan
Prior art keywords
polypeptide
release system
poi
exosome
construct
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019514870A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019520852A (ja
JP6855567B2 (ja
Filing date
Publication date
Priority claimed from GBGB1609216.5A external-priority patent/GB201609216D0/en
Application filed filed Critical
Publication of JP2019520852A publication Critical patent/JP2019520852A/ja
Publication of JP2019520852A5 publication Critical patent/JP2019520852A5/ja
Priority to JP2021042290A priority Critical patent/JP7483648B2/ja
Application granted granted Critical
Publication of JP6855567B2 publication Critical patent/JP6855567B2/ja
Priority to JP2024074429A priority patent/JP2024103494A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019514870A 2016-05-25 2017-05-25 治療的ポリペプチドを含むエクソソーム Active JP6855567B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2021042290A JP7483648B2 (ja) 2016-05-25 2021-03-16 治療的ポリペプチドを含むエクソソーム
JP2024074429A JP2024103494A (ja) 2016-05-25 2024-05-01 治療的ポリペプチドを含むエクソソーム

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1609216.5A GB201609216D0 (en) 2016-05-25 2016-05-25 Exosomes comprising therapeutic polypeptides
GB1609216.5 2016-05-25
PCT/GB2017/051479 WO2017203260A1 (en) 2016-05-25 2017-05-25 Exosomes comprising therapeutic polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021042290A Division JP7483648B2 (ja) 2016-05-25 2021-03-16 治療的ポリペプチドを含むエクソソーム

Publications (3)

Publication Number Publication Date
JP2019520852A JP2019520852A (ja) 2019-07-25
JP2019520852A5 true JP2019520852A5 (cg-RX-API-DMAC7.html) 2020-11-12
JP6855567B2 JP6855567B2 (ja) 2021-04-07

Family

ID=56369954

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019514870A Active JP6855567B2 (ja) 2016-05-25 2017-05-25 治療的ポリペプチドを含むエクソソーム
JP2021042290A Active JP7483648B2 (ja) 2016-05-25 2021-03-16 治療的ポリペプチドを含むエクソソーム
JP2024074429A Pending JP2024103494A (ja) 2016-05-25 2024-05-01 治療的ポリペプチドを含むエクソソーム

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021042290A Active JP7483648B2 (ja) 2016-05-25 2021-03-16 治療的ポリペプチドを含むエクソソーム
JP2024074429A Pending JP2024103494A (ja) 2016-05-25 2024-05-01 治療的ポリペプチドを含むエクソソーム

Country Status (17)

Country Link
US (2) US11534499B2 (cg-RX-API-DMAC7.html)
EP (3) EP3782646B1 (cg-RX-API-DMAC7.html)
JP (3) JP6855567B2 (cg-RX-API-DMAC7.html)
KR (1) KR102253731B1 (cg-RX-API-DMAC7.html)
CN (2) CN109715211B (cg-RX-API-DMAC7.html)
AU (1) AU2017270932B2 (cg-RX-API-DMAC7.html)
BR (1) BR112018074229A2 (cg-RX-API-DMAC7.html)
CA (1) CA3024020C (cg-RX-API-DMAC7.html)
DK (1) DK3463465T3 (cg-RX-API-DMAC7.html)
ES (1) ES2836553T3 (cg-RX-API-DMAC7.html)
GB (1) GB201609216D0 (cg-RX-API-DMAC7.html)
MX (1) MX378381B (cg-RX-API-DMAC7.html)
PT (1) PT3463465T (cg-RX-API-DMAC7.html)
RU (1) RU2737732C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201810116VA (cg-RX-API-DMAC7.html)
WO (1) WO2017203260A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201807945B (cg-RX-API-DMAC7.html)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
GB201609216D0 (en) 2016-05-25 2016-07-06 Evox Therapeutics And Isis Innovation Ltd Exosomes comprising therapeutic polypeptides
KR20240007715A (ko) 2016-10-14 2024-01-16 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵염기 에디터의 aav 전달
WO2018165504A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Suppression of pain by gene editing
KR20190123328A (ko) 2017-03-09 2019-10-31 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 암 백신
EP3658573A1 (en) 2017-07-28 2020-06-03 President and Fellows of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
WO2019032628A1 (en) 2017-08-07 2019-02-14 The Regents Of The University Of California GENERATING PLATFORM FOR SAFE CELLULAR THERAPEUTIC AGENTS
GB2568255A (en) * 2017-11-08 2019-05-15 Evox Therapeutics Ltd Exosomes comprising RNA therapeutics
CA3095134A1 (en) 2018-03-28 2019-10-03 Board Of Regents, The University Of Texas System Identification of epigenetic alterations in dna isolated from exosomes
AU2019255765B2 (en) * 2018-04-19 2025-02-06 Board Of Regents, The University Of Texas System Therapeutic modulation of tumor suppressors using exosomes
CN108753806A (zh) * 2018-06-20 2018-11-06 中国人民解放军第四军医大学 增强目标rna装载入外泌体的融合蛋白的表达载体及其构建方法和应用
CN108753822A (zh) * 2018-06-20 2018-11-06 中国人民解放军第四军医大学 递送融合型rna结合蛋白的表达载体及其制备方法和应用
EP3820495A4 (en) 2018-07-09 2022-07-20 The Broad Institute Inc. RNA-PROGRAMMABLE EPIGENETIC RNA MODIFIERS AND THEIR USES
EP3841217A4 (en) * 2018-08-24 2022-05-18 University Of Delaware EXTRACELLULAR VESICLES AS BIOMARKERS AND THERAPEUTICS FOR NEUROMUSCULAR DISEASES
CN109293745A (zh) * 2018-09-04 2019-02-01 暨南大学 一种运载蛋白、重组表达载体、外泌体及制备方法与应用
CN109321596B (zh) * 2018-09-05 2021-12-17 暨南大学 一种包载蛋白的外泌体的制备方法与应用
CN109234237B (zh) * 2018-09-30 2020-08-07 中国人民解放军第四军医大学 一种装载ABCA1 mRNA的外泌体及其构建方法和应用
CN113272426A (zh) * 2018-11-16 2021-08-17 医福斯治疗有限公司 用于尿素循环蛋白和核酸的替代的细胞外囊泡
US20220008520A1 (en) * 2018-11-21 2022-01-13 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods and materials for reducing age-related striated muscle and cognitive decline
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
WO2020152298A1 (en) * 2019-01-24 2020-07-30 Fundació Hospital Universitari Vall D'hebron - Institut De Recerca Method for producing enzymes
JP2022519275A (ja) * 2019-02-04 2022-03-22 コディアック バイオサイエンシーズ, インコーポレイテッド エクソソーム操作のための膜タンパク質足場
WO2020191241A1 (en) 2019-03-19 2020-09-24 The Broad Institute, Inc. Methods and compositions for editing nucleotide sequences
KR20210141554A (ko) * 2019-03-21 2021-11-23 코디악 바이오사이언시즈, 인크. 세포외 소포 접합체 및 이의 용도
WO2020214842A1 (en) 2019-04-17 2020-10-22 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
WO2020231700A1 (en) * 2019-05-11 2020-11-19 Youngsuk Yi Neurotoxin compositions and methods
US20220259617A1 (en) 2019-06-13 2022-08-18 The General Hospital Corporation Engineered human-endogenous virus-like particles and methods of use thereof for delivery to cells
AU2020298314A1 (en) * 2019-06-21 2022-02-03 Entelexo Biotherapeutics Inc. Platforms, compositions, and methods for therapeutics delivery
KR102125567B1 (ko) 2019-07-02 2020-06-22 한양대학교 에리카산학협력단 식물 엑소좀의 대량 생산 방법
CN120771302A (zh) * 2019-08-14 2025-10-14 隆萨销售股份公司 与分子连接的细胞外囊泡及其用途
WO2021039884A1 (ja) * 2019-08-28 2021-03-04 国立研究開発法人理化学研究所 細胞膜透過性ベシクル
GB201915855D0 (en) * 2019-10-31 2019-12-18 Univ Oxford Innovation Ltd An extracellular vesicle
CN110954703A (zh) * 2019-12-27 2020-04-03 杭州迪相实业有限公司 一种同时检测外泌体内蛋白和rna、外泌体膜蛋白的方法
KR20220139926A (ko) 2020-02-05 2022-10-17 다이아뎀 바이오쎄라퓨틱스 인크 인공 시냅스
KR102688170B1 (ko) * 2020-02-10 2024-07-24 주식회사 엑소스템텍 광 절단성 단백질을 포함하는 엑소좀 및 이의 이용
JP7479078B2 (ja) * 2020-02-10 2024-05-08 株式会社エキソステムテック 光切断性タンパク質を含むエクソソーム及びその用途
US20230096378A1 (en) 2020-03-12 2023-03-30 Institute For Basic Science Composition for inducing apoptosis of cells having genomic sequence variation and method for inducing apoptosis of cells by using composition
EP4127136A4 (en) * 2020-03-31 2024-04-03 Ilias Biologics Inc. USE OF DELIVERY OF NF-KB INHIBITORS FROM EXOSOMES
US12472228B2 (en) 2020-03-31 2025-11-18 Ilias Biologics Inc. Use of exosome-based delivery of NF-κB inhibitors
WO2021223659A1 (en) * 2020-05-06 2021-11-11 Nanjing Iaso Biotherapeutics Co., Ltd. Extracellular vesicles targeting cancer cells and uses thereof
CN111569077B (zh) * 2020-05-29 2021-10-26 南方医科大学 Flot2抑制剂在抑制破骨细胞形成和/或破骨活性中的应用
BR112023001272A2 (pt) 2020-07-24 2023-04-04 Massachusetts Gen Hospital Partículas semelhantes a vírus aprimoradas e métodos de uso das mesmas para entrega às células
RU2766707C1 (ru) * 2020-11-13 2022-03-15 Федеральное государственное бюджетное образовательное учреждение высшего образования «Московский государственный университет имени М.В.Ломоносова» (МГУ) Средство для лечения фиброза тканей на основе компонентов секретома мезенхимных стромальных клеток, способ получения и применения средства
CN112773775B (zh) * 2021-01-13 2022-12-20 广东药科大学 一种负载去甲斑蝥素外泌体的制备方法及其应用
WO2022158836A1 (ko) * 2021-01-21 2022-07-28 주식회사 엑소코바이오 목적 단백질 또는 펩타이드가 융합가능한 Fc 수용체 또는 이의 일부를 포함하는 재조합 엑소좀 및 이의 용도
US20240182890A1 (en) 2021-04-07 2024-06-06 Astrazeneca Ab Compositions and methods for site-specific modification
WO2022215078A1 (en) * 2021-04-07 2022-10-13 Ramot At Tel-Aviv University Ltd. Modified cannabinoids and uses thereof
JP2024514671A (ja) * 2021-04-22 2024-04-02 オハイオ・ステイト・イノベーション・ファウンデーション 腫瘍関連マクロファージを標的とするためのナノキャリア
GB202107182D0 (en) * 2021-05-19 2021-06-30 Evox Therapeutics Ltd Nanoparticle delivery system for production of engineered extracellular vesicles
EP4357611A4 (en) 2021-06-16 2024-09-25 NSK Ltd. Load estimating device for rolling bearing, control device for mechanical device provided with rolling bearing, load estimating method, and program
CA3226019A1 (en) 2021-07-20 2023-01-26 Ags Therapeutics Sas Extracellular vesicles from microalgae, their preparation, and uses
EP4414455A4 (en) 2021-10-07 2026-01-07 H U Group Res Institute G K STRUCTURE
US20250223584A2 (en) 2021-12-03 2025-07-10 The Broad Institute, Inc. Compositions and methods for efficient in vivo delivery
WO2023144127A1 (en) 2022-01-31 2023-08-03 Ags Therapeutics Sas Extracellular vesicles from microalgae, their biodistribution upon administration, and uses
JP2025519070A (ja) 2022-05-17 2025-06-24 エンヴェロップ セラピューティクス, インコーポレイテッド 効率的in vivo送達のための組成物および方法
WO2023232976A1 (en) 2022-06-03 2023-12-07 Ags Therapeutics Sas Extracellular vesicles from genetically-modified microalgae containing endogenously-loaded cargo, their preparation, and uses
GB202211033D0 (en) * 2022-07-28 2022-09-14 Glaxosmithkline Biologicals Sa Purification process
US20240050523A1 (en) * 2022-08-11 2024-02-15 Shiftbio Inc. Method for inducing resolutive macrophage and uses therof
JP2025535944A (ja) 2022-10-24 2025-10-30 エイジーエス・セラピューティクス・ソシエテ・パール・アクシオン・サンプリフィエ 微細藻類由来の細胞外小胞、鼻腔内投与時のそれらの生体内分布、及びそれらの使用
CN116803424B (zh) * 2023-08-24 2023-11-28 上海懿贝瑞生物医药科技有限公司 Slc17a5基因抑制剂及其用途
KR20250040552A (ko) * 2023-09-14 2025-03-24 주식회사 엑소스템텍 퇴행성 뇌질환 치료 단백질을 포함하는 엑소좀을 이용한 뇌 특이적 퇴행성 뇌질환 치료 단백질 전달 기술
WO2025143942A1 (ko) * 2023-12-29 2025-07-03 (주)에스엔이바이오 신경 펩타이드가 탑재된 세포외소포 및 이의 용도
WO2025172421A1 (en) 2024-02-14 2025-08-21 Astrazeneca Ab Compositions and methods for treatment of huntington's disease
WO2025176843A1 (en) 2024-02-21 2025-08-28 Ags Therapeutics Sas Microalgae extracellular vesicle based gene therapy vectors (mev-gtvs), their preparation, and uses thereof
WO2025196641A1 (ru) * 2024-03-19 2025-09-25 Биоплатформ Гмбх Гибридные частицы, способ их получения и применение
GB2702728A (en) * 2024-10-29 2026-06-24 Evox Therapeutics Ltd Crispr rna molecules for improved ev-mediated delivery of cas12 rnp complexes

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834247A (en) 1992-12-09 1998-11-10 New England Biolabs, Inc. Modified proteins comprising controllable intervening protein sequences or their elements methods of producing same and methods for purification of a target protein comprised by a modified protein
US5935822A (en) * 1995-03-21 1999-08-10 The Regents Of The University Of Colorado Product and process for membrane and soluble polypeptide segregation
GB0112687D0 (en) * 2001-05-24 2001-07-18 Microbiological Res Authority Pharmaceutical use of secreted bacterial effector proteins
UA100127C2 (ru) 2007-08-20 2012-11-26 Онкотерапи Саенс, Инк. Пептид cdh3 и лекарственное средство, содержащее его
KR101543624B1 (ko) 2007-08-20 2015-08-11 온코세라피 사이언스 가부시키가이샤 Foxm1 펩티드 및 이를 포함하는 약학적 조성물
EP2127640A1 (en) 2008-05-27 2009-12-02 Koninklijke Philips Electronics N.V. Azide modified proteins
GB201121070D0 (en) * 2011-12-07 2012-01-18 Isis Innovation composition for delivery of biotherapeutics
CN103205435A (zh) 2013-04-11 2013-07-17 浙江大学 利用内含肽系统大肠杆菌表达乳铁蛋白改良肽lf-6的方法
EP2983721B2 (en) * 2013-04-12 2021-01-20 Evox Therapeutics Limited Therapeutic delivery vesicles
CN105283553B (zh) 2013-06-11 2021-06-25 克隆技术实验室有限公司 蛋白质富集的微泡及其制备和使用方法
WO2015002956A1 (en) 2013-07-01 2015-01-08 Ohio State Innovation Foundation Exosome delivery system
WO2015120548A1 (en) 2014-02-11 2015-08-20 The Governors Of The University Of Alberta Genetically encoded photocleavable proteins
WO2015138878A1 (en) 2014-03-13 2015-09-17 Research Institute At Nationwide Children's Hospital, Inc. Methods of delivering heparin binding epidermal growth factor using stem cell generated exosomes
WO2016077639A2 (en) 2014-11-12 2016-05-19 VL27, Inc. Nanovesicular therapies
KR20160130937A (ko) * 2015-05-04 2016-11-15 한국과학기술원 목적 단백질을 포함하는 엑소솜의 제조 방법 및 상기 제조 방법에 의해 제조된 엑소솜을 이용하여 목적 단백질을 세포질로 전달시키는 방법
WO2016178532A1 (ko) * 2015-05-04 2016-11-10 한국과학기술원 목적 단백질을 포함하는 엑소솜의 제조 방법 및 상기 제조 방법에 의해 제조된 엑소솜을 이용하여 목적 단백질을 세포질로 전달시키는 방법
EP3445378A1 (en) * 2016-04-22 2019-02-27 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and vaccine compositions for the treatment of b-cell malignancies
GB201609216D0 (en) 2016-05-25 2016-07-06 Evox Therapeutics And Isis Innovation Ltd Exosomes comprising therapeutic polypeptides

Similar Documents

Publication Publication Date Title
RU2018145738A (ru) Экзосомы, содержащие терапевтические полипептиды
RU2020118554A (ru) Экзосомы, содержащие рнк-терапевтические средства
JP2024103494A5 (cg-RX-API-DMAC7.html)
JP2021507682A5 (cg-RX-API-DMAC7.html)
AU2021232753B2 (en) T cell recruiting polypeptides based on TCR alpha/beta reactivity
JP7526501B2 (ja) エクスビボのbite活性化t細胞
EP3715373A1 (en) Novel scfv amino acid sequence, chimeric antigen receptor comprising same and application thereof
JP2018528786A5 (cg-RX-API-DMAC7.html)
RU2018104703A (ru) Опухолеспецифичное антитело против egfr и его применение
Alonso-Camino et al. CARbodies: human antibodies against cell surface tumor antigens selected from repertoires displayed on T cell chimeric antigen receptors
CN105384825A (zh) 一种基于单域抗体的双特异性嵌合抗原受体及其应用
RU2018107802A (ru) Полностью человеческие антитела к мезотелину и иммунные эффекторные клетки, нацеленные на мезотелин
JP2018524282A5 (cg-RX-API-DMAC7.html)
JP2017529067A5 (cg-RX-API-DMAC7.html)
RU2019129917A (ru) Химерный антигенный рецептор
JP2021518116A5 (cg-RX-API-DMAC7.html)
CN114380905B (zh) 靶向SARS-CoV-2RBD蛋白的鲨源纳米抗体、制备方法和应用
CN115850474B (zh) 一种il-8单克隆抗体及其应用
CN116554326B (zh) 一种靶向cd22同种异体通用car-t细胞的制备及用途
CN105505869A (zh) 一种针对肿瘤干细胞的嵌合抗原受体t细胞
CN106928363B (zh) 一种FAP纳米抗体Nb12
Hammink et al. Affinity-Based Purification of Polyisocyanopeptide Bioconjugates
CN108530538B (zh) EpCAM单域抗体E6
CN106928365B (zh) 一种FAP纳米抗体Nb36
JP2017536821A5 (cg-RX-API-DMAC7.html)